Robert Koski - Dec 11, 2024 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role: Director
Signature: /s/ Julio C. Esquivel, as Attorney-in-Fact for Robert Koski
Stock symbol: OGEN
Transactions as of: Dec 11, 2024
Transactions value $: $0
Form type: 4
Date filed: 12/13/2024, 04:05 PM
Previous filing: Sep 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGEN	Common Stock	Conversion of derivative security		+5K	+27.22%		23.4K	Dec 11, 2024	See Footnote	F1, F2, F3
holding	OGEN	Common Stock						27.9K	Dec 11, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGEN	Series B Convertible Preferred Stock	Conversion of derivative security		-1.5M	-100%		0	Dec 11, 2024	Common Stock	5K		See Footnote	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
F2	Represents the full conversion of Series B Convertible Preferred Stock ("Series B") held by the KFLP into shares of common stock, pursuant to, and in accordance with, the certificate of designation for the Series B.
F3	The Series B was convertible into common stock at any time and had no expiration date. The Series B was issued on November 8, 2017, with an original issue price of $0.50 per share. On January 19, 2018, the Issuer effected a 1-for-10 reverse stock split, and on January 20, 2023, the Issuer effected a one-for-sixty reverse stock split, which collectively resulted in an adjusted conversion price of $300.00 per share.